Changes in Breast Cancer Screening Prevalence in the US During the COVID-19 Pandemic, 2018-2022

医学 乳腺摄影术 行为危险因素监测系统 乳腺癌 大流行 乳腺癌筛查 人口学 2019年冠状病毒病(COVID-19) 癌症筛查 癌症 妇科 内科学 疾病 人口 环境卫生 传染病(医学专业) 社会学
作者
Kilan C. Ashad‐Bishop,Jessica Star,Angela N. Giaquinto,Robert A. Smith,Ahmedin Jemal,Priti Bandi
出处
期刊:Cancer Epidemiology, Biomarkers & Prevention [American Association for Cancer Research]
标识
DOI:10.1158/1055-9965.epi-24-0540
摘要

Abstract Background: Annual mammography screening declined year-on-year during the COVID-19 pandemic through 2021. This study examined changes in 2022 compared to 2018 in the national prevalence of self-reported up-to-date mammography. Methods: Using 2018-2022 data from the Center for Disease Control and Prevention's (CDC) Behavioral Risk Factor Surveillance System (BRFSS), we assess relative changes defined as annual prevalence ratios (aPR) in the SR receipt of past-year and up-to-date (UTD) breast cancer screening (bi-annual mammography in women ages 50-74 years) during the third year of the COVID-19 pandemic overall and by sociodemographic characteristics. Results: UTD BC screening declined for the first time since 2018 (2018 compared to 2022, from 78.7% to 76.6%; aPR, 0.97; 95% CI, 0.96-0.98), despite a small increase in past-year breast cancer screening from 2020 and 2022 (57.9% to 59.6%; aPR, 1.03; 95% CI, 1.01-1.05). This translated to 747,791 fewer women reporting UTD with recommended BC screening in 2022 vs. 2018. UTD BC screening declines between 2018-2022 were largest for American Indian/Alaska Native women (74.8% to 62.2%; aPR, 0.83; 95% CI, 0.74-0.93), women with less formal educational attainment (< high school: 73.1% to 65.5%; aPR, 0.9; 95% CI, 0.85-0.95), and women without a usual source of care (48% to 42.9%; aPR, 0.85; 95% CI, 0.78-0.92). Conclusions: Previously noted pandemic-related declines in past-year BC screening now reflect in women reporting being UTD, with the largest declines in AI/AN and lower SES women. Impact: Future studies should monitor screening prevalence in relation to BC diagnostic stage, overall and by sociodemographic groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
inshialla完成签到 ,获得积分10
2秒前
张章发布了新的文献求助10
2秒前
3秒前
4秒前
Orange应助月亮是甜的采纳,获得10
4秒前
结实的妙梦完成签到,获得积分10
4秒前
6秒前
6秒前
6秒前
7秒前
9秒前
真知灼见关注了科研通微信公众号
9秒前
Mess完成签到 ,获得积分10
10秒前
10秒前
10秒前
Olivia完成签到,获得积分10
11秒前
11秒前
张章完成签到,获得积分20
11秒前
Blummer发布了新的文献求助10
11秒前
小马发布了新的文献求助10
12秒前
整齐新儿发布了新的文献求助10
12秒前
自然的真发布了新的文献求助10
12秒前
hcq完成签到 ,获得积分20
12秒前
14秒前
14秒前
15秒前
大侠发布了新的文献求助10
15秒前
16秒前
三金发布了新的文献求助10
16秒前
万能毒药完成签到 ,获得积分10
17秒前
乐乐应助整齐新儿采纳,获得10
17秒前
Wdwpp发布了新的文献求助10
17秒前
17秒前
传奇3应助小马采纳,获得10
17秒前
开放的斌发布了新的文献求助10
17秒前
小二郎应助suyanive采纳,获得10
18秒前
Shine发布了新的文献求助10
18秒前
优秀的排球完成签到 ,获得积分10
19秒前
20秒前
21秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3459147
求助须知:如何正确求助?哪些是违规求助? 3053698
关于积分的说明 9037829
捐赠科研通 2742963
什么是DOI,文献DOI怎么找? 1504592
科研通“疑难数据库(出版商)”最低求助积分说明 695334
邀请新用户注册赠送积分活动 694644